300294 博雅生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.5393.2746.1686.3006.486
总资产报酬率 ROA (%)5.1632.9945.5225.3924.994
投入资产回报率 ROIC (%)5.4483.2336.0816.0135.686

边际利润分析
销售毛利率 (%)66.66652.75854.65756.98258.074
营业利润率 (%)38.57513.39519.29116.71613.189
息税前利润/营业总收入 (%)36.69812.18818.36815.94113.417
净利润/营业总收入 (%)33.1249.35716.14813.51710.953

收益指标分析
经营活动净收益/利润总额(%)81.526159.564100.786108.37291.941
价值变动净收益/利润总额(%)14.28528.2018.2409.7293.091
营业外收支净额/利润总额(%)0.025-0.428-0.0340.014-1.013

偿债能力分析
流动比率 (X)12.01014.0828.6118.9483.358
速动比率 (X)10.86612.8627.6657.8762.567
资产负债率 (%)7.0606.4909.3169.2010.187
带息债务/全部投入资本 (%)1.6930.8300.7080.8198.373
股东权益/带息债务 (%)5,787.18911,905.02713,936.38612,032.5001,083.961
股东权益/负债合计 (%)1,316.2591,440.684960.198973.774425.214
利息保障倍数 (X)-19.450-10.600-20.046-20.50537.259

营运能力分析
应收账款周转天数 (天)54.53245.58059.16560.91472.950
存货周转天数 (天)385.280175.840193.372215.694223.947